OPENLANE EVP sells 66,709 shares after option exercise
OPENLANE, Inc. executive Tobin P. Richer reported option exercises and stock sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OPENLANE, Inc. executive Tobin P. Richer reported option exercises and stock sales. On May 6, 2026, he exercised options for a total of 66,709 shares of common stock at exercise prices of $13.81 and $18.23 per share, then sold 66,709 shares in open-market transactions.
The sales occurred at weighted average prices around $35.57–$36.02 per share, across multiple trades within the ranges detailed in the footnotes. After these transactions, Richer directly owned 28,697 shares of OPENLANE common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 6,917 | $13.81 | $96K |
| Exercise | Employee Stock Option (right to buy) | 13,014 | $18.23 | $237K |
| Exercise | Employee Stock Option (right to buy) | 20,751 | $13.81 | $287K |
| Exercise | Employee Stock Option (right to buy) | 26,027 | $18.23 | $474K |
| Exercise | Common Stock | 6,917 | $13.81 | $96K |
| Sale | Common Stock | 3,784 | $35.57 | $135K |
| Sale | Common Stock | 3,133 | $36.01 | $113K |
| Exercise | Common Stock | 13,014 | $18.23 | $237K |
| Sale | Common Stock | 7,209 | $35.57 | $256K |
| Sale | Common Stock | 5,805 | $36.01 | $209K |
| Exercise | Common Stock | 20,751 | $13.81 | $287K |
| Sale | Common Stock | 10,878 | $35.57 | $387K |
| Sale | Common Stock | 9,873 | $36.02 | $356K |
| Exercise | Common Stock | 26,027 | $18.23 | $474K |
| Sale | Common Stock | 14,419 | $35.57 | $513K |
| Sale | Common Stock | 11,608 | $36.01 | $418K |
Footnotes (8)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.930 to $35.925 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.930 to $36.080 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.930 to $36.100 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.930 to $36.135 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. These options were granted on March 4, 2021 and vested and became exercisable in equal installments on each of the first four anniversaries of the grant date, and were subject to continued employment through such vesting date.
- F6. These options were granted on June 4, 2021 and vested and became exercisable in equal installments on each of the first four anniversaries of the grant date, and were subject to continued employment through such vesting date.
- F7. These options were granted on March 4, 2021 and become eligible to vest and become exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $18.81, $23.81, $28.81, and $33.81, for twenty consecutive trading days, subject to continued employment through such vesting date.
- F8. These options were granted on June 4, 2021 and will become eligible to vest and become exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $23.23, $28.23, $33.23, and $38.23, for twenty consecutive trading days, subject to continued employment through such vesting date.
Key Figures
Key Terms
open-market sale financial
Employee Stock Option (right to buy) financial
weighted average price financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OPENLANE (OPLN) EVP Tobin Richer report in this Form 4?
Did Tobin Richer retain any stock options after the reported OPENLANE transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.